These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 792987

  • 1. Immunological follow-up of 41 renal allograft recipients.
    Birkeland SA.
    Scand J Urol Nephrol; 1976; (31 Suppl):3-37. PubMed ID: 792987
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of IgM, IgD, IgA and IgG before and during rejection of renal allotransplants.
    Hrncír Z, Erben J, Tichý M.
    Czech Med; 1979; 2(3):148-56. PubMed ID: 394945
    [Abstract] [Full Text] [Related]

  • 3. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E, Sansonetti P, Nesci C, Famulari A, Cortesini R.
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [Abstract] [Full Text] [Related]

  • 4. Dermatitis herpetiformis: lymphocytes, immunoglobulins and complement factors in peripheral blood.
    Braathen LR, Førre O, Natvig JB.
    Acta Derm Venereol; 1979; 59(1):39-44. PubMed ID: 84465
    [Abstract] [Full Text] [Related]

  • 5. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A, Valdivia LA, Murase N, Woo J, Celli S, Fung JJ, Starzl TE, Demetris AJ.
    Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
    [Abstract] [Full Text] [Related]

  • 6. Immunological evaluation of renal transplant patients: changes in levels of beta-2-microglobulin, immunoglobulins and complement components during graft rejection.
    Barnes RM, Hart CA, Alexander LC, Steen S.
    J Clin Lab Immunol; 1983 Sep; 12(1):17-22. PubMed ID: 6355478
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H, Otte B, Lang D, Heidenreich S.
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S.
    Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499
    [Abstract] [Full Text] [Related]

  • 9. [Hyperacute rejection of an HL-A identical renal allograft (author's transl)].
    Wiedermann G, Stemberger H, Ambrosch F, Tappeiner G, Schadlbauer B, Kux M.
    Wien Klin Wochenschr; 1977 Jan 07; 89(1):11-3. PubMed ID: 319603
    [Abstract] [Full Text] [Related]

  • 10. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S, Liu M, Chen J, Yin L, Sha G, Chen H, Liu Z, Li L.
    Clin Transplant; 2004 Oct 07; 18(5):536-40. PubMed ID: 15344956
    [Abstract] [Full Text] [Related]

  • 11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov 07; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 12. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP, Pertosa G, Manno C, Losuriello V, Pastore A.
    Minerva Chir; 1980 May 31; 35(10):709-14. PubMed ID: 7005726
    [Abstract] [Full Text] [Related]

  • 13. [Serum immunoglobulins during immunosuppressive therapy following kidney transplantation].
    Oehninger H, Joller H, Largiadèr F, Binswanger U.
    Schweiz Med Wochenschr; 1978 Apr 01; 108(13):486-9. PubMed ID: 345436
    [Abstract] [Full Text] [Related]

  • 14. [Serum complement components C3, C4 and immunoglobulins IgG, IgM, IgA after renal transplantation (author's transl)].
    Schmidt P.
    Wien Klin Wochenschr; 1974 Apr 05; 86(7):177-89. PubMed ID: 4362660
    [No Abstract] [Full Text] [Related]

  • 15. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug 05; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 16. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A, Deka R, Bhowmik D, Tiwari SC, Mehra NK.
    Transplant Proc; 2004 Jun 05; 36(5):1336-9. PubMed ID: 15251326
    [Abstract] [Full Text] [Related]

  • 17. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R.
    Transplantation; 1995 Nov 15; 60(9):1016-23. PubMed ID: 7491675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complement and sepsis.
    Gutiérrez-Fernández J, Maroto MC, Piédrola G, Zamora E.
    Allergol Immunopathol (Madr); 1987 Nov 15; 15(3):145-9. PubMed ID: 3661354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.